| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TELO | Telomir Pharmaceuticals, Inc. | Chief Financial Officer | $151K | Aug 27, 2024 | ||
| INTI | Inhibitor Therapeutics, Inc. | Director | Dec 31, 2024 | |||
| MIRA | MIRA PHARMACEUTICALS, INC. | Chief Financial Officer | Dec 9, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|